⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18622092 | 1.00 | — | — | |
| SCHEMBL12092812 | 1.00 | — | — | |
| SCHEMBL12092809 | 1.00 | — | — | |
| SCHEMBL19263924 | 1.00 | — | — | |
| SCHEMBL11892456 | 1.00 | — | — | |
| SCHEMBL12934029 | 1.00 | — | — | |
| SCHEMBL8045792 | 0.90 | — | — | |
| SCHEMBL19263830 | 0.90 | — | — | |
| SCHEMBL18530020 | 0.90 | — | — | |
| SCHEMBL17379575 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9982194-B2 | Liquid-crystalline media | MERECK PATENT GMBH (DE) | 2018-05-29 | — | — | US | disclosed |
| US-9777216-B2 | Liquid crystalline medium | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2017-10-03 | — | — | US | disclosed |
| US-9593279-B2 | Liquid-crystalline medium and high-frequency components comprising same | MERCK PATENT GMBH (DE) | 2017-03-14 | — | — | US | disclosed |
| US-20170044102-A1 | New Method for Preparing Isofagomine and Its Derivatives | AMICUS THERAPEUTICS INC (US) | 2017-02-16 | — | — | US | disclosed |
| US-9481700-B2 | Method for preparing isofagomine and its derivatives | AMICUS THERAPEUTICS, INC. (US) | 2016-11-01 | — | — | US | disclosed |
| US-9090822-B2 | Polymerizable compounds and the use thereof in liquid crystal displays | MERCK PATENT GMBH (DE) | 2015-07-28 | — | — | US | disclosed |
| US-20150203758-A1 | LIQUID-CRYSTALLINE MEDIA | MERCK PATENT GMBH (DE) | 2015-07-23 | — | — | US | disclosed |
| US-8487110-B2 | Method for preparing isofagomine and its derivatives | AMICUS THERAPEUTICS, INC. (US) | 2013-07-16 | — | — | US | disclosed |
| US-20120305843-A1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-12-06 | — | — | US | disclosed |
| US-20120224124-A1 | POLYMERIZABLE COMPOUNDS AND THE USE THEREOF IN LIQUID CRYSTAL DISPLAYS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-09-06 | — | — | US | disclosed |
| US-7863453-B2 | Tartrate salt of isofagomine and methods of use | AMICUS THERAPEUTICS, INC. (US) | 2011-01-04 | — | — | US | disclosed |
| US-20100160638-A1 | NEW METHOD FOR PREPARING ISOFAGOMINE AND ITS DERIVATIVES | AMICUS THERAPEUTICS, INC. (US) | 2010-06-24 | — | — | US | disclosed |
| US-20090176830-A1 | TARTRATE SALT OF ISOFAGOMINE AND METHODS OF USE | AMICUS THERAPEUTICS, INC. (US) | 2009-07-09 | — | — | US | disclosed |
| US-7501439-B2 | Tartrate salt of isofagomine and methods of use | AMICUS THERAPEUTICS, INC. (US) | 2009-03-10 | — | — | US | disclosed |
| US-20070281975-A1 | Tartrate Salt of Isofagomine and Methods of Use | AMICUS THERAPEUTICS, INC. | 2007-12-06 | — | — | US | disclosed |